CAS: 306959-01-3
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide REF: IN-DA01C0KFCAS: 306959-01-3 | 95% | 81,00 €~509,00 € | Lun 25 Nov 24 | |
MYLS22 REF: TM-T9127CAS: 306959-01-3 | 98.82% - 99.77% | 41,00 €~862,00 € | Lun 02 Dic 24 | |
MYLS22 REF: 3D-GMA95901CAS: 306959-01-3 | Min. 95% | Prezzo su richiesta | Mar 07 Gen 25 |
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide
CAS:306959-01-3
Formula:
C24H21N5O2S
Purezza:
95%
Peso molecolare:
443.5208
Ref: IN-DA01C0KF
5mg | 81,00 € | ||
25mg | 125,00 € | ||
50mg | 198,00 € | ||
100mg | 226,00 € | ||
250mg | 509,00 € |
Consegna stimata in Stati Uniti, il Lunedì 25 Novembre 2024
MYLS22
CAS:306959-01-3
MYLS22: selective OPA1 inhibitor, halts tumor growth & angiogenesis, affects NFkB & gene expression, anti-cancer …
Formula:
C24H21N5O2S
Purezza:
98.82% - 99.77%
Colore e forma:
Solid
Peso molecolare:
443.52
Ref: TM-T9127
2mg | 41,00 € | ||
5mg | 62,00 € | ||
10mg | 94,00 € | ||
25mg | 160,00 € | ||
50mg | 235,00 € | ||
100mg | 366,00 € | ||
200mg | 545,00 € | ||
500mg | 862,00 € | ||
1mL*10mM (DMSO) | 69,00 € |
Consegna stimata in Stati Uniti, il Lunedì 02 Dicembre 2024
MYLS22
CAS:306959-01-3
Versatile small molecule scaffold
Formula:
C24H21N5O2S
Purezza:
Min. 95%
Peso molecolare:
443.5 g/mol
Ref: 3D-GMA95901
50mg | 245,00 € | ||
500mg | 974,00 € |
Consegna stimata in Stati Uniti, il Martedì 07 Gennaio 2025